The Insulin-Only Bionic Pancreas Pivotal Trial

NACompletedINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

March 31, 2020

Primary Completion Date

October 30, 2021

Study Completion Date

January 14, 2022

Conditions
Diabetes MellitusType 1 DiabetesDiabetes Mellitus, Type 1
Interventions
COMBINATION_PRODUCT

Bionic Pancreas (BP) with Aspart or Lispro

iLet Bionic Pancreas System, which consists of an integrated infusion pump, touchscreen display, Bluetooth radio, and insulin dosing algorithms, that automatically controls insulin delivery based on glucose values obtained by communicating with a Dexcom G6 sensor using lispro or aspart insulin.

COMBINATION_PRODUCT

Bionic Pancreas with Fiasp (BPFiasp)

iLet Bionic Pancreas System, which consists of an integrated infusion pump, touchscreen display, Bluetooth radio, and insulin dosing algorithms, that automatically controls Fiasp insulin delivery based on glucose values obtained by communicating with a Dexcom G6 sensor.

OTHER

Usual Care (UC)

Using pre-study insulin regimen with the Dexcom G6 CGM

OTHER

BP Guidance Insulin Dosing

Pre-study insulin delivery method with SMBG and blinded CGM with dosing guidance by the BP

Trial Locations (16)

10032

Naomi Berrie Diabetes Center at Columbia University (Pediatrics), New York

20010

Children's National Health System (Pediatrics), Washington D.C.

27517

University of Noth Carolina- Chapel Hill (Adults), Chapel Hill

30322

Emory University (Pediatrics), Atlanta

32207

Nemours Children's Clinic (Pediatrics), Jacksonville

44195

Cleveland Clinic (Adults), Cleveland

48202

Henry Ford Health System (Adults), Detroit

63110

Washington University (Adults), St Louis

75390

University of Texas- Southwestern (Pediatrics and Adults), Dallas

78229

University of Texas Health Science Center (Pediatrics), San Antonio

80045

Barbara Davis Center for Diabetes (Pediatrics and Adults), Aurora

92037

University of California - San Diego (Adults), San Diego

92868

Children's Hospital of Orange County (Pediatrics), Orange

94305

Stanford University (Pediatrics and Adults), Stanford

98109

University of Washington (Adults), Seattle

02114

Massachusetts General Hospital - Diabetes Research Center (Peds and Adults), Boston

Sponsors
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Beta Bionics, Inc.

INDUSTRY

collaborator

Boston University

OTHER

collaborator

Massachusetts General Hospital

OTHER

lead

Jaeb Center for Health Research

OTHER